Zdrowie i gospodarka · 21/04/2011

FDA Announces Grant Funds for Analgesic Clinical Trials Innovation Initiative

The Food and Drug Administration (FDA) is announcing the availability of grant funds to support the Analgesic Clinical Trials Innovation, Opportunities, and Networks (ACTION) Initiative, which aims to streamline the discovery and development of new analgesic drug products for public health. The initiative will address major gaps in scientific information to speed up analgesic clinical trials and drug development.